extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes
Here's my review of the PR:
- Factual accuracy — The claims and evidence presented are factually correct, drawing from the NEJM FLOW trial and FDA indications.
- Intra-PR duplicates…
extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
Vida Domain Peer Review — PR #902
McKinsey Facility-to-Home: 2 new claims + 5 enrichments
Critical: Temporal Staleness on the Core Claim
The `home-based-care-could-capture-265-bil…
extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
- Factual accuracy — The claims and entities are factually correct, drawing information from a McKinsey report and market data.
- Intra-PR duplicates — There are no intra-PR…